Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rigouts

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2018
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation studyM Tadesse, G Abebe, A Bekele, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 19, 2014
Is frontloaded sputum microscopy an option in active tuberculosis case finding?N Lorent, J Buyze, T Kim, et al.
Applied and Environmental Microbiology|September 1, 2019
Public Microbial Resource Centers: Key Hubs for Findable, Accessible, Interoperable, and Reusable (FAIR) Microorganisms and Genetic MaterialsP Becker, M Bosschaerts, P Chaerle, et al.
Scientific Reports|June 27, 2023
Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678J Snobre, M C Villellas, N Coeck, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 12, 2009
First molecular epidemiological study of tuberculosis in BeninD Affolabi, G Anyo, F Faïhun, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|August 19, 2007
[Primary and acquired resistance to antituberculous drugs in strains of Mycobacterium tuberculosis isolated in Rwanda]A N Umubyeyi, L Rigouts, G Zissis, et al.
IJTLD Open|July 22, 2024
Prevalence and predictors of NTM in presumed/confirmed drug-resistant TBE T Abbew, R Laryea, F Sorvor, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 10, 2015
Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patientsA Van Deun, K J M Aung, A Hossain, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 26, 1999
Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimensA Van Deun, K J Aung, S Chowdhury, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Reply to Schön et al., "Quality control and considering systematic MIC shifts are key when evaluating the role of <i>mmpR5</i> (<i>Rv0678</i>) frameshifts in bedaquiline resistance"J Snobre, C J Meehan, W Mulders, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2018
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation studyM Tadesse, G Abebe, A Bekele, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 19, 2014
Is frontloaded sputum microscopy an option in active tuberculosis case finding?N Lorent, J Buyze, T Kim, et al.
Applied and Environmental Microbiology|September 1, 2019
Public Microbial Resource Centers: Key Hubs for Findable, Accessible, Interoperable, and Reusable (FAIR) Microorganisms and Genetic MaterialsP Becker, M Bosschaerts, P Chaerle, et al.
Scientific Reports|June 27, 2023
Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678J Snobre, M C Villellas, N Coeck, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 12, 2009
First molecular epidemiological study of tuberculosis in BeninD Affolabi, G Anyo, F Faïhun, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|August 19, 2007
[Primary and acquired resistance to antituberculous drugs in strains of Mycobacterium tuberculosis isolated in Rwanda]A N Umubyeyi, L Rigouts, G Zissis, et al.
IJTLD Open|July 22, 2024
Prevalence and predictors of NTM in presumed/confirmed drug-resistant TBE T Abbew, R Laryea, F Sorvor, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 10, 2015
Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patientsA Van Deun, K J M Aung, A Hossain, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 26, 1999
Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimensA Van Deun, K J Aung, S Chowdhury, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Reply to Schön et al., "Quality control and considering systematic MIC shifts are key when evaluating the role of <i>mmpR5</i> (<i>Rv0678</i>) frameshifts in bedaquiline resistance"J Snobre, C J Meehan, W Mulders, et al.
Pageof 9